Cost-Benefit Analysis of Capsule Endoscopy Compared With Standard Upper Endoscopy for the Detection of Barrett's Esophagus

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 3, 2007, Pages

  Gerson, Lauren ^a   Lin, Otto S ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CAPSULE ENDOSCOPY; COST BENEFIT ANALYSIS; HUMAN; PROBABILITY; SEDATION; STANDARDIZATION;

EID: 33947103061     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.12.022     Document Type: Article

References (84)

1. Heartburn across America: a Gallup Organization national survey (1988), Gallup Organization, Princeton, NJ
2. Nebel O.T., Forbes M.F., and Castell D.O. Symptomatic GE reflux: incidence and precipitating factors. Am J Dig Dis 21 (1976) 953-956
3. Reid B.J., and Weinstein W.M. Barrett's esophagus and adenocarcinoma. Annu Rev Med 38 (1987) 477-492
4. Lagergren J., Bergstrom R., Lindgren A., et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340 (1999) 825-831
5. Gerson L.B., Edson R., Lavori P.W., et al. Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. Am J Gastroenterol 96 (2001) 2005-2012
6. Falk G.W. Endoscopic surveillance of Barrett's esophagus: risk stratification and cancer risk. Gastrointest Endosc 49 (1999) S29-S34
7. Koslowsky B., Jacob H., Eliakim R., et al. PillCam ESO in esophageal studies: improved diagnostic yield of 14 frames per second (fps) compared with 4 fps. Endoscopy 38 (2006) 27-30
8. Gerson L.B., and Triadafilopoulos G. Screening for esophageal adenocarcinoma: an evidence-based approach. Am J Med 113 (2002) 499-505
9. Eliakim R., Sharma V.K., Yassin K., et al. A prospective study of the diagnostic accuracy of PillCam ESO esophageal capsule endoscopy versus conventional upper endoscopy in patients with chronic gastroesophageal reflux diseases. J Clin Gastroenterol 39 (2005) 572-578
10. Lin OS, Schembre DB, Mergener K, et al. Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux. Gastrointest Endosc In press.
11. Russell L.B., Siegel J.E., Daniels N., et al. Cost-Effectiveness analysis as a guide to resource allocation in health: roles and limitations. In: Gold M.R., Siegel J.E., Russell L.B., et al. (Eds). Cost-effectiveness in health and medicine (1996), Oxford University Press, New York 3-23
12. Gerson L.B., Groeneveld P.W., and Triadafilopoulos G. Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2 (2004) 868-879
13. Sampliner R.E. Practice Parameters Committee of the American College of Gastroenterology updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 97 (2002) 1888-1895
14. Eloubeidi M.A., and Provenzale D. Does this patient have Barrett's esophagus?. the utility of predicting Barrett's esophagus at the index endoscopy. Am J Gastroenterol 94 (1999) 937-943
15. Rex D.K., Cummings O.W., Shaw M., et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125 (2003) 1670-1677
16. Spechler S.J., Jain S.K., Tendler D.A., et al. Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 16 (2002) 1795-1800
17. Csendes A., Smok G., Burdiles P., et al. Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux. Dis Esophagus 13 (2000) 5-11
18. Hirota W.K., Loughney T.M., Lazas D.J., et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 116 (1999) 277-285
19. Aldulaimi D.M., Cox M., Nwokolo C.U., et al. Barrett's surveillance is worthwhile and detects curable cancers: a prospective cohort study addressing cancer incidence, treatment outcome and survival. Eur J Gastroenterol Hepatol 17 (2005) 943-950
20. Miros M., Kerlin P., and Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut 32 (1991) 1441-1446
21. Weston A.P., Badr A.S., and Hassanein R.S. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 94 (1999) 3413-3419
22. Sharma P., Weston A.P., Morales T., et al. Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut 46 (2000) 9-13
23. Guardino J.M., Khandwala F., Lopez R., et al. Barrett's esophagus at a tertiary care center: association of age on incidence and prevalence of dysplasia and adenocarcinoma. Am J Gastroenterol 101 (2006) 2187-2193
24. Hameeteman W., Tytgat G.N., Houthoff H.J., et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 96 (1989) 1249-1256
25. Sharma P., Morales T.G., Bhattacharyya A., et al. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Am J Gastroenterol 92 (1997) 2012-2016
26. Conio M., Blanchi S., Lapertosa G., et al. Long-term endoscopic surveillance of patients with Barrett's esophagus: incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol 98 (2003) 1931-1939
27. Ferraris R., Bonelli L., Conio M., et al. Incidence of Barrett's adenocarcinoma in an Italian population: an endoscopic surveillance programme-Gruppo Operativo per lo Studio delle Precancerosi Esofagee (GOSPE). Eur J Gastroenterol Hepatol 9 (1997) 881-885
28. Kerlin P., d'Mellow G., and van Deth A. Barrett's esophagus: clinical, endoscopic, and histologic spectrum in fifty patients. Aust N Z J Med 16 (1986) 198-205
29. Spechler S.J., Robbins A.H., Rubins H.B., et al. Adenocarcinoma and Barrett's esophagus. an overrated risk?. Gastroenterology 87 (1984) 927-933
30. Cameron A.J., Ott B.J., and Payne W.S. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 313 (1985) 857-859
31. Williamson W.A., Ellis Jr. F.H., Gibb S.P., et al. Barrett's esophagus: prevalence and incidence of adenocarcinoma. Arch Intern Med 151 (1991) 2212-2216
32. Drewitz D.J., Sampliner R.E., and Garewal H.S. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92 (1997) 212-215
33. Lapalus M.G., Dumortier J., Fumex F., et al. Esophageal capsule endoscopy versus esophagogastroduodenoscopy for evaluating portal hypertension: a prospective comparative study of performance and tolerance. Endoscopy 38 (2006) 36-41
34. Zaman A., Hapke R., Sahagun G., et al. Unsedated peroral endoscopy with a video ultrathin endoscope: patient acceptance, tolerance, and diagnostic accuracy. Am J Gastroenterol 93 (1998) 1260-1263
35. Saeian K., Staff D.M., Vasilopoulos S., et al. Unsedated transnasal endoscopy accurately detects Barrett's metaplasia and dysplasia. Gastrointest Endosc 56 (2002) 472-478
36. Silvis S.E., Nebel O., Rogers G., et al. Endoscopic complications: results of the 1974 American Society for Gastrointestinal Endoscopy survey. JAMA 235 (1976) 928-930
37. Clarke G.A., Jacobson B.C., Hammett R.J., et al. The indications, utilization and safety of gastrointestinal endoscopy in an extremely elderly patient cohort. Endoscopy 33 (2001) 580-584
38. Sieg A., Hachmoeller-Eisenbach U., and Eisenbach T. Prospective evaluation of complications in outpatient GI endoscopy: a survey among German gastroenterologists. Gastrointest Endosc 53 (2001) 620-627
39. Schauer P.R., Schwesinger W.H., Page C.P., et al. Complications of surgical endoscopy: a decade of experience from a surgical residency training program. Surg Endosc 11 (1997) 8-11
40. Bini E.J., Firoozi B., Choung R.J., et al. Systematic evaluation of complications related to endoscopy in a training setting: a prospective 30-day outcomes study. Gastrointest Endosc 57 (2003) 8-16
41. O'Connor J.B., Falk G.W., and Richter J.E. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol 94 (1999) 2037-2042
42. Katz D., Rothstein R., Schned A., et al. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol 93 (1998) 536-541
43. Skacel M., Petras R.E., Gramlich T.L., et al. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol 95 (2000) 3383-3387
44. Weston A.P., Badr A.S., and Hassanein R.S. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 94 (1999) 3413-3419
45. Schnell T.G., Sontag S.J., Chejfec G., et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 120 (2001) 1607-1619
46. Rossi M., Barreca M., de Bortoli N., et al. Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study. Ann Surg 243 (2006) 58-63
47. Weston A.P., Sharma P., Topalovski M., et al. Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol 95 (2000) 1888-1893
48. Provenzale D., Schmitt C., and Wong J.B. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 94 (1999) 2043-2053
49. Inadomi J.M., Sampliner R., Lagergren J., et al. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med 138 (2003) 176-186
50. Streitz Jr. J.M., Andrews Jr. C.W., and Ellis Jr. F.H. Endoscopic surveillance of Barrett's esophagus: does it help?. J Thorac Cardiovasc Surg 105 (1993) 383-387
51. Lerut T., Coosemans W., Van Raemdonck D., et al. Surgical treatment of Barrett's carcinoma: correlations between morphologic findings and prognosis. J Thorac Cardiovasc Surg 107 (1994) 1059-1065
52. Corley D.A., Levin T.R., Habel L.A., et al. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 122 (2002) 633-640
53. Heitmiller R.F., Redmond M., and Hamilton S.R. Barrett's esophagus with high-grade dysplasia: an indication for prophylactic esophagectomy. Ann Surg 224 (1996) 66-71
54. Edwards M.J., Gable D.R., Lentsch A.B., et al. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg 223 (1996) 585-589
55. Incarbone R., Bonavina L., Saino G., et al. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus. Surg Endosc 16 (2002) 263-266
56. Moraca R.J., and Low D.E. Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch Surg 141 (2006) 545-549
57. Headrick J.R., Nichols III F.C., Miller D.L., et al. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg 73 (2002) 1697-1702
58. Tseng E.E., Wu T.T., Yeo C.J., et al. Barrett's esophagus with high grade dysplasia. Surgical results and long-term outcome: an update. J Gastrointest Surg 7 (2003) 164-171
59. Ellis Jr. F.H., Heatley G.J., Krasna M.J., et al. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg 113 (1997) 836-846
60. Scott Bolton J., Wu T.T., and Yeo C.J. Esophagectomy for adenocarcinoma in patients 45 years of age and younger. J Gastrointest Surg 5 (2001) 620-625
61. Hulscher J.B., van Sandick J.W., de Boer A.G., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347 (2002) 1662-1669
62. Rice T.W., Falk G.W., Achkar E., et al. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 88 (1993) 1832-1836
63. Zaninotto G., Parenti A.R., Ruol A., et al. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. Br J Surg 87 (2000) 1102-1105
64. Begg C.B., Cramer L.D., Hoskins W.J., et al. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 280 (1998) 1747-1751
65. Birkmeyer J.D., Siewers A.E., Finlayson E.V., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 346 (2002) 1128-1137
66. Dimick J.B., Pronovost P.J., Cowan J.A., et al. Surgical volume and quality of care for esophageal resection: do high-volume hospitals have fewer complications?. Ann Thorac Surg 75 (2003) 337-341
67. Peters J.H., Clark G.W., Ireland A.P., et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 108 (1994) 813-821
68. Bonavina L., Via A., Incarbone R., et al. Results of surgical therapy in patients with Barrett's adenocarcinoma. World J Surg 27 (2003) 1062-1066
69. Ell C., May A., Gossner L., et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 118 (2000) 670-677
70. May A., Gossner L., Pech O., et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 14 (2002) 1085-1091
71. Conio M., Repici A., Cestari R., et al. Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience. World J Gastroenterol 11 (2005) 6650-6655
72. Ahmad N.A., Kochman M.L., Wong W.B., et al. Efficacy, safety, and clinical outcomes of endoscopic mucosal resection: a study of 101 cases. Gastrointest Endosc 55 (2002) 390-396
73. Overholt B.F., Panjehpour M., and Haydek J.M. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 49 (1999) 1-7
74. Wolfsen H.C., Woodward T.A., and Raimondo M. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Mayo Clin Proc 77 (2002) 1176-1181
75. Overholt B.F., Panjehpour M., and Halberg D.L. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc 58 (2003) 183-188
76. Foroulis C.N., and Thorpe J.A. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer. Eur J Cardiothorac Surg 29 (2006) 30-34
77. Panjehpour M., Overholt B.F., Haydek J.M., et al. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation. Am J Gastroenterol 95 (2000) 2177-2184
78. Weston A.P., and Sharma P. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma. Am J Gastroenterol 97 (2002) 2998-3006
79. Van Laethem J.L., Jagodzinski R., Peny M.O., et al. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma. Endoscopy 33 (2001) 257-261
80. Lightdale C.J., Heier S.K., Marcon N.E., et al. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Hd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc 42 (1995) 507-512
81. Fisher R.S., Bromer M.Q., Thomas R.M., et al. Predictors of recurrent specialized intestinal metaplasia after complete laser ablation. Am J Gastroenterol 98 (2003) 1945-1951
82. Ackroyd R., Tam W., Schoeman M., et al. Prospective randomized controlled trial of argon plasma coagulation ablation vs endoscopic surveillance of patients with Barrett's esophagus after antireflux surgery. Gastrointest Endosc 59 (2004) 1-7
83. Overholt B.F., Lightdale C.L., Wang K.K., et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62 (2005) 488-498
84. Ramirez F.C., Shaukat M.S., Young M.A., et al. Feasibility and safety of string, wireless capsule endoscopy in the diagnosis of Barrett's esophagus. Gastrointest Endosc 61 (2005) 741-746